Extrawell Pharmaceutical Holdings Limited
Research Extrawell Pharmaceutical Holdings Limited (0858.HK) on Bullrun: market cap HKD 205.90M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0858.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 205.90M
- Financial periodFY2025
- RevenueHKD 55.43M
- Revenue growth-6.2%
- Net incomeHKD 222.64M
- Free cash flow-HKD 7.44M
- Gross margin39.5%
Valuation Snapshot
latest market cap is HKD 205.90M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 55.43M | HKD 222.64M | -HKD 7.44M | 39.5% | 0.07 | HKD 77.77M | HKD 140.94M | HKD 1.33B |
| FY2024 | HKD 59.10M | -HKD 162.95M | -HKD 4.89M | 48.7% | -0.07 | HKD 93.61M | HKD 120.41M | HKD 1.11B |
| FY2023 | HKD 72.58M | HKD 129.27M | -HKD 5.44M | 42.9% | 0.04 | HKD 102.40M | HKD 103.22M | HKD 1.28B |
| FY2022 | HKD 73.93M | HKD 130.59M | -HKD 11.39M | 50.8% | 0.04 | HKD 111.88M | HKD 85.31M | HKD 1.17B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 205.90M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sell of pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Manufacturing and Trading segments. The company manufactures transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Extrawell Pharmaceutical Holdings Limited's market cap?
Extrawell Pharmaceutical Holdings Limited's market capitalization is HKD 205.90M.
What does Extrawell Pharmaceutical Holdings Limited do?
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sell of pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Manufacturing and Trading segments.